{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:52:35Z","timestamp":1793015555292,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC1187"],"award-info":[{"award-number":["2022NSFSC1187"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC1365"],"award-info":[{"award-number":["2022NSFSC1365"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22277083"],"award-info":[{"award-number":["22277083"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903502"],"award-info":[{"award-number":["81903502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ejmech.2023.115102","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T11:17:59Z","timestamp":1673090279000},"page":"115102","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases"],"prefix":"10.1016","volume":"248","author":[{"given":"Xin","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leihao","family":"Sha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6143-5943","authenticated-orcid":false,"given":"Wuyu","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jifa","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115102_bib1","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/j.1600-0854.2008.00790.x","article-title":"AAK1 regulates Numb function at an early step in clathrin-mediated endocytosis","volume":"9","author":"Sorensen","year":"2008","journal-title":"Traffic"},{"key":"10.1016\/j.ejmech.2023.115102_bib2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.str.2015.12.015","article-title":"Family-wide structural analysis of human numb-associated protein kinases","volume":"24","author":"Sorrell","year":"2016","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2023.115102_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.embor.embor776","article-title":"The Ark1\/Prk1 family of protein kinases","volume":"4","author":"Smythe","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.ejmech.2023.115102_bib4","doi-asserted-by":"crossref","first-page":"11932","DOI":"10.1158\/0008-5472.CAN-06-3220","article-title":"Endocytic Ark\/Prk kinases play a critical role in Adriamycin resistance in both yeast and mammalian cells","volume":"66","author":"Takahashi","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115102_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1398-9219.2003.0142.x","article-title":"AAK1-mediated mu 2 phosphorylation is stimulated by assembled clathrin","volume":"4","author":"Conner","year":"2003","journal-title":"Traffic"},{"key":"10.1016\/j.ejmech.2023.115102_bib6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1083\/jcb.200108123","article-title":"Identification of an adaptor-associated kinase, AAK1, as a regulator of clathrin-mediated endocytosis","volume":"156","author":"Conner","year":"2002","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.ejmech.2023.115102_bib7","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1091\/mbc.e06-09-0831","article-title":"A novel AAK1 splice variant functions at multiple steps of the endocytic Pathway","volume":"18","author":"Henderson","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2023.115102_bib8","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.neuron.2012.01.019","article-title":"Chemical genetic identification of NDR1\/2 kinase substrates AAK1 and Rabin8 uncovers their roles in dendrite arborization and spine development","volume":"73","author":"Ultanir","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2023.115102_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cellsig.2019.03.012","article-title":"Identification of novel PCTAIRE-1\/CDK16 substrates using a chemical genetic screen","volume":"59","author":"Shehata","year":"2019","journal-title":"Cell. Signal."},{"key":"10.1016\/j.ejmech.2023.115102_bib10","doi-asserted-by":"crossref","first-page":"e2556","DOI":"10.1002\/brb3.2556","article-title":"miRNA-384-3p alleviates sevoflurane-induced nerve injury by inhibiting Aak1 kinase in neonatal rats","volume":"12","author":"Chen","year":"2022","journal-title":"Brain and Behavior,"},{"key":"10.1016\/j.ejmech.2023.115102_bib11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2023.115102_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ceb.2017.02.013","article-title":"Fast and ultrafast endocytosis","volume":"47","author":"Watanabe","year":"2017","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib13","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm3151","article-title":"Molecular mechanism and physiological functions of clathrin-mediated endocytosis","volume":"12","author":"McMahon","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib14","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016972","article-title":"Endocytosis of viruses and bacteria","volume":"6","author":"Cossart","year":"2014","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib15","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acschemneuro.0c00176","article-title":"Defining the neural kinome: strategies and opportunities for small molecule drug discovery to target neurodegenerative diseases","volume":"11","author":"Krahn","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115102_bib16","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s12031-018-1085-3","article-title":"Periodic variation of AAK1 in an A beta(1-42)-induced mouse model of Alzheimer's disease","volume":"65","author":"Fu","year":"2018","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115102_bib17","doi-asserted-by":"crossref","first-page":"22918","DOI":"10.3390\/ijms151222918","article-title":"Dysfunction of endocytic kinase AAK1 in ALS","volume":"15","author":"Shi","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115102_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2350-10-98","article-title":"Genomewide association study for onset age in Parkinson disease","volume":"10","author":"Latourelle","year":"2009","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ejmech.2023.115102_bib19","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/acs.jmedchem.1c00335","article-title":"Kinases as potential therapeutic targets for anti-coronaviral therapy","volume":"65","author":"Pillaiyar","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/13543776.2021.1928637","article-title":"A patent review of adaptor associated kinase 1 (AAK1) inhibitors (2013-present)","volume":"31","author":"Martinez-Gualda","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2023.115102_bib21","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1021\/acs.jmedchem.0c00606","article-title":"COVID-19: drug targets and potential treatments","volume":"63","author":"Gil","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib22","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1473-3099(20)30132-8","article-title":"COVID-19: combining antiviral and anti-inflammatory treatments","volume":"20","author":"Stebbing","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2023.115102_bib23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.ejmech.2023.115102_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104787","article-title":"The FDA-approved drug Ivermectin inhibits the replication of SARS-CoV-2 in vitro","volume":"178","author":"Caly","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115102_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/s41422-020-0305-x","article-title":"Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion","volume":"30","author":"Xia","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2023.115102_bib26","doi-asserted-by":"crossref","first-page":"105608","DOI":"10.1016\/j.micpath.2022.105608","article-title":"Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system","volume":"168","author":"Punekar","year":"2022","journal-title":"Microbial Pathogenesis"},{"key":"10.1016\/j.ejmech.2023.115102_bib27","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1021\/acs.jmedchem.0c01467","article-title":"Recent developments in the use of kinase inhibitors for management of viral infections","volume":"65","author":"Raghuvanshi","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib28","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2023.115102_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1124\/jpet.116.235333","article-title":"Inhibition of AAK1 kinase as a novel therapeutic approach to treat neuropathic pain","volume":"358","author":"Kostich","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2023.115102_bib30","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1021\/acs.jmedchem.9b00136","article-title":"Synthesis and structure\u2013activity relationships of 3, 5-disubstituted-pyrrolo [2, 3-b] pyridines as inhibitors of adaptor-associated kinase 1 with antiviral activity","volume":"62","author":"Verdonck","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib31","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41419-022-05151-7","article-title":"Novel 1-hydroxy phenothiazinium-based derivative protects against bacterial sepsis by inhibiting AAK1-mediated LPS internalization and caspase-11 signaling","volume":"13","author":"Yuan","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2023.115102_bib32","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nature24046","article-title":"Nucleosome\u2013Chd1 structure and implications for chromatin remodelling","volume":"550","author":"Farnung","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115102_bib33","doi-asserted-by":"crossref","first-page":"818(","DOI":"10.1016\/j.chembiol.2019.02.021","article-title":"Leveraging compound promiscuity to identify targetable cysteines within the kinome","volume":"26","author":"Rao","year":"2019","journal-title":"Cell Chemical Biology"},{"key":"10.1016\/j.ejmech.2023.115102_bib34","article-title":"The adaptor-associated kinase, AAK1, regulates cargo selection by AP2 complexes","volume":"13","author":"Conner","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.ejmech.2023.115102_bib35","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.tibs.2021.01.011","article-title":"Direct structural insights into GABAA receptor pharmacology","volume":"46","author":"Kim","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2023.115102_bib36","first-page":"200","article-title":"AAK1 and GAK inhibitors demonstrate activity against Filoviruses","author":"Dorosky","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejmech.2023.115102_bib37","volume":"vol. 184","author":"Pu","year":"2020"},{"key":"10.1016\/j.ejmech.2023.115102_bib38","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0960-9822(03)00579-7","article-title":"The actin-regulating kinase Prk1p negatively regulates Scd5p, a suppressor of clathrin deficiency, in actin organization and endocytosis","volume":"13","author":"Henry","year":"2003","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib39","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.chembiol.2011.03.017","article-title":"AAK1 identified as an inhibitor of neuregulin-1\/ErbB4-dependent neurotrophic factor signaling using integrative chemical genomics and proteomics","volume":"18","author":"Kuai","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib40","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-018-0100-2","article-title":"Notch and interacting signalling pathways in cardiac development, disease, and regeneration","volume":"15","author":"MacGrogan","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ejmech.2023.115102_bib41","doi-asserted-by":"crossref","first-page":"18720","DOI":"10.1074\/jbc.M110.190769","article-title":"The adaptor-associated kinase 1, AAK1, is a positive regulator of the Notch pathway","volume":"286","author":"Gupta-Rossi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111188","article-title":"Neuronal paxillin and drebrin mediate BDNF-induced force transduction and growth cone turning in a soft-tissue-like environment","volume":"40","author":"Chen","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2023.115102_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.celrep.2018.12.023","article-title":"WNT activates the AAK1 kinase to promote clathrin-mediated endocytosis of LRP6 and establish a negative feedback loop","volume":"26","author":"Agajanian","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejmech.2023.115102_bib44","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-Catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115102_bib45","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2011.08.028","article-title":"Nak regulates localization of clathrin sites in higher-order dendrites to promote local dendrite growth","volume":"72","author":"Yang","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2023.115102_bib46","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/nn.4357","article-title":"Diminished KCC2 confounds synapse specificity of LTP during senescence","volume":"19","author":"Ferando","year":"2016","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115102_bib47","series-title":"Advances in Pharmacology","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/bs.apha.2014.11.007","article-title":"Chapter four - restoring the spinal pain gate: GABAA receptors as targets for novel analgesics","author":"Zeilhofer","year":"2015"},{"key":"10.1016\/j.ejmech.2023.115102_bib48","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2023.115102_bib49","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamaneurol.2017.0486","article-title":"Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy","volume":"74","author":"Hoffman","year":"2017","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.ejmech.2023.115102_bib50","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/ALN.0000000000000963","article-title":"Differential opioid tolerance and opioid-induced hyperalgesia: a clinical reality","volume":"124","author":"Hayhurst","year":"2016","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2023.115102_bib51","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","article-title":"Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable mendelian randomization analysis","volume":"78","author":"Rosoff","year":"2021","journal-title":"JAMA Psychiatr."},{"key":"10.1016\/j.ejmech.2023.115102_bib52","first-page":"22","article-title":"Novel pharmacological nonopioid therapies in chronic pain","author":"Kaye","year":"2018","journal-title":"Curr. Pain Headache Rep."},{"key":"10.1016\/j.ejmech.2023.115102_bib53","doi-asserted-by":"crossref","first-page":"11454","DOI":"10.1021\/acs.jmedchem.2c00844","article-title":"Progress and challenges in targeted protein degradation for neurodegenerative disease therapy","volume":"65","author":"Fang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib54","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.bbr.2017.02.007","article-title":"Intracerebroventricular injection of beta-amyloid in mice is associated with long-term cognitive impairment in the modified hole-board test","volume":"324","author":"Schmid","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2023.115102_bib55","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1126\/science.279.5354.1113g","article-title":"\u03b1-Synuclein gene and Parkinson's disease","volume":"279","author":"Brice","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115102_bib56","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1016\/j.apsb.2021.02.016","article-title":"Targeting autophagy using small-molecule compounds to improve potential therapy of Parkinson's disease","volume":"11","author":"Zhang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2023.115102_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ajmg.b.30195","article-title":"Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms","volume":"137B","author":"Zhang","year":"2005","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"key":"10.1016\/j.ejmech.2023.115102_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"362","author":"Rosen","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115102_bib59","doi-asserted-by":"crossref","first-page":"16478","DOI":"10.1073\/pnas.0806195105","article-title":"Kinase requirements in human cells: II. Genetic interaction screens identify kinase requirements following HPV16 E7 expression in cancer cells","volume":"105","author":"Baldwin","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmech.2023.115102_bib60","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tra.12389","article-title":"Fusion of enveloped viruses in endosomes","volume":"17","author":"White","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.ejmech.2023.115102_bib61","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1094\/MPMI.2002.15.8.774","article-title":"pH regulates endoglucanase expression and virulence of Alternaria alternata persimmon fruit","volume":"15","author":"Eshel","year":"2002","journal-title":"Mol. Plant Microbe Interact."},{"key":"10.1016\/j.ejmech.2023.115102_bib62","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","article-title":"Baricitinib as potential treatment for 2019-nCoV acute respiratory disease","volume":"395","author":"Richardson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115102_bib63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115102_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.577032","article-title":"The landscape of coronavirus disease 2019 (COVID-19) and integrated analysis SARS-CoV-2 receptors and potential inhibitors in lung adenocarcinoma patients","volume":"8","author":"Tang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib65","first-page":"22","article-title":"A Phase I\/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: a structured summary of a study protocol for a randomised controlled trial","author":"Moreno-Gonzalez","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.ejmech.2023.115102_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115162","article-title":"JAK inhibition as a new treatment strategy for patients with COVID-19","volume":"202","author":"Huang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115102_bib67","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AAK1 and GAK regulate hepatitis C virus entry and are potential drug targets","volume":"89","author":"Neveu","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2023.115102_bib68","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1128\/JVI.02705-14","article-title":"AP-2-Associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets","volume":"89","author":"Neveu","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2023.115102_bib69","doi-asserted-by":"crossref","first-page":"10935","DOI":"10.1128\/JVI.00750-12","article-title":"Hepatitis C virus induces epidermal growth factor receptor activation via CD81 binding for viral internalization and entry","volume":"86","author":"Diao","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.ejmech.2023.115102_bib70","article-title":"The serine\/threonine kinase AP2-associated kinase 1 plays an important role in rabies virus entry","volume":"12","author":"Wang","year":"2020","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.ejmech.2023.115102_bib71","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3390\/life10090170","article-title":"Rhabdovirus infection is dependent on serine\/threonine kinase AP2-associated kinase 1","volume":"10","author":"Luo","year":"2020","journal-title":"Life"},{"key":"10.1016\/j.ejmech.2023.115102_bib72","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.antiviral.2018.05.001","article-title":"Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment","volume":"155","author":"Pu","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejmech.2023.115102_bib73","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1172\/JCI89857","article-title":"Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects","volume":"127","author":"Bekerman","year":"2017","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejmech.2023.115102_bib74","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1158\/2326-6066.CIR-20-0056","article-title":"A genetic screen to identify gain- and loss-of-function modifications that enhance T-cell infiltration into tumors","volume":"8","author":"Rogers","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ejmech.2023.115102_bib75","article-title":"Identification and validation of a prognostic gene signature for diffuse large B-cell lymphoma based on tumor microenvironment-related genes","volume":"11","author":"Pan","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2023.115102_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114062","article-title":"DYRK1A inhibitors for disease therapy: current status and perspectives","volume":"229","author":"Liu","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib77","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1021\/cb500129t","article-title":"Exploration of type II binding mode: a privileged approach for kinase inhibitor focused drug discovery?","volume":"9","author":"Zhao","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib78","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nchembio799","article-title":"Rational design of inhibitors that bind to inactive kinase conformations","volume":"2","author":"Liu","year":"2006","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib79","doi-asserted-by":"crossref","first-page":"10133","DOI":"10.1021\/acs.jmedchem.2c00614","article-title":"Polo-like kinase 1 inhibitors in human cancer therapy: development and therapeutic potential","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib80","doi-asserted-by":"crossref","first-page":"11090","DOI":"10.1021\/acs.jmedchem.1c00472","article-title":"Discovery, structure-activity relationships, and in vivo evaluation of novel aryl amides as brain penetrant adaptor protein 2-associated kinase 1 (AAK1) inhibitors for the treatment of neuropathic pain","volume":"64","author":"Hartz","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib81","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1021\/acs.jmedchem.1c02131","volume":"65","author":"Luo","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib82","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.115102_bib83","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2023.115102_bib84","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/cn100007x","article-title":"Defining desirable central nervous system drug space through the alignment of molecular properties, in vitro ADME, and safety attributes","volume":"1","author":"Wager","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115102_bib85","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1021\/acs.jmedchem.1c02132","article-title":"Discovery and optimization of biaryl alkyl ethers as a novel class ofHighly selective, CNS-penetrable, and orally active AdaptorProtein-2-associated kinase 1 (AAK1) inhibitors for the PotentialTreatment of neuropathic pain","volume":"65","author":"Luo","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib86","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.bmcl.2010.01.077","article-title":"Discovery of potent and selective bicyclic A2B adenosine receptor antagonists via bioisosteric amide replacement","volume":"20","author":"Eastwood","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115102_bib87","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1016\/j.bmcl.2019.07.033","article-title":"Applications of amide isosteres in medicinal chemistry","volume":"29","author":"Sun","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2023.115102_bib88","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1021\/acs.jmedchem.1c01966","article-title":"Bicyclic heterocyclic replacement of an aryl amide leading to potent and kinase-selective adaptor protein 2-associated kinase 1 inhibitors","volume":"65","author":"Hartz","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib89","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neuropharm.2017.03.015","article-title":"H-3 BMT-046091 a potent and selective radioligand to determine AAK1 distribution and target engagement","volume":"118","author":"Louis","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2023.115102_bib90","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1126\/science.aaa3778","article-title":"Combating emerging viral threats","volume":"348","author":"Bekerman","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115102_bib91","doi-asserted-by":"crossref","first-page":"7898","DOI":"10.1021\/jm8011036","article-title":"Assessment of chemical coverage of kinome space and its implications for kinase drug discovery","volume":"51","author":"Bamborough","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib92","doi-asserted-by":"crossref","first-page":"5810","DOI":"10.1021\/acs.jmedchem.9b00136","article-title":"Synthesis and structure-activity relationships of 3,5-Disubstituted-pyrrolo 2,3-b pyridines as inhibitors of adaptor-associated kinase 1 with antiviral activity","volume":"62","author":"Verdonck","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib93","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.e21683","article-title":"Neurophysiological changes: sunitinib fatigue severity","volume":"34","author":"Cunningham","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2023.115102_bib94","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa1507247","article-title":"Baricitinib in patients with refractory rheumatoid arthritis","volume":"374","author":"Genovese","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2023.115102_bib95","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.cell.2020.11.007","article-title":"Baricitinib treatment resolves lower airway inflammation and neutrophil recruitment in SARS-CoV-2-infected rhesus macaques","volume":"184","author":"Hoang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115102_bib96","article-title":"Fedratinib becomes new option in myelofibrosis","volume":"9","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejmech.2023.115102_bib97","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/jcb.30243","article-title":"Computational profiling of natural compounds as promising inhibitors against the spike proteins of SARS-CoV-2 wild-type and the variants of concern, viral cell-entry process, and cytokine storm in COVID-19","volume":"123","author":"Kar","year":"2022","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ejmech.2023.115102_bib98","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.drudis.2021.11.013","article-title":"Repurposing drugs in autophagy for the treatment of cancer: from bench to bedside","volume":"27","author":"Bu","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115102_bib99","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1126\/science.1125951","article-title":"Targeting tyrosine kinases in cancer: the second wave","volume":"312","author":"Baselga","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115102_bib100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature04874","article-title":"Mechanisms of drug inhibition of signalling molecules","volume":"441","author":"Sebolt-Leopold","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115102_bib101","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/emm.2006.48","article-title":"SP600125, a selective JNK inhibitor, aggravates hepatic ischemia-reperfusion injury","volume":"38","author":"Lee","year":"2006","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ejmech.2023.115102_bib102","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3389\/fonc.2020.01428","article-title":"Tyrosine kinase inhibitors play an antiviral action in patients affected by chronic myeloid leukemia: a possible model supporting their use in the fight against SARS-CoV-2","volume":"10","author":"Galimberti","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ejmech.2023.115102_bib103","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cell.2016.04.015","article-title":"Bacterial outer membrane vesicles mediate cytosolic localization of LPS and caspase-11 activation","volume":"165","author":"Vanaja","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2023.115102_bib104","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1126\/science.1230751","article-title":"Caspase-11 protects against bacteria that escape the vacuole","volume":"339","author":"Aachoui","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115102_bib105","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/chir.23040","article-title":"(5Z)-7-Oxozeaenol: a novel and potent resorcylic acid lactone kinase inhibitor with a cis-enone Michael acceptor","volume":"31","author":"Ellestad","year":"2019","journal-title":"Chirality"},{"key":"10.1016\/j.ejmech.2023.115102_bib106","doi-asserted-by":"crossref","first-page":"6777","DOI":"10.1007\/s11164-016-2525-8","article-title":"Biological potential of pyrimidine derivatives in a new era","volume":"42","author":"Rani","year":"2016","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2023.115102_bib107","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/acs.jmedchem.1c00440","article-title":"Identification of pyrimidine-based lead compounds for understudied kinases implicated in driving neurodegeneration","volume":"65","author":"Drewry","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.815567","article-title":"Quadruple target evaluation of diversity-optimized halogen-enriched fragments (HEFLibs) reveals substantial ligand efficiency for AP2-associated protein kinase 1 (AAK1)","volume":"9","author":"Dammann","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib109","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nbt.3374","article-title":"Comprehensive characterization of the published kinase inhibitor set","volume":"34","author":"Elkins","year":"2016","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2023.115102_bib110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1021\/acsmedchemlett.9b00399","article-title":"SGC-AAK1-1: a chemical probe targeting AAK1 and BMP2K","volume":"11","author":"Wells","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115102_bib111","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1021\/acs.jmedchem.1c00980","article-title":"Chemical probes for understudied kinases: challenges and opportunities","volume":"65","author":"Serafim","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib112","doi-asserted-by":"crossref","first-page":"5618","DOI":"10.1016\/j.bmc.2013.04.080","article-title":"A 2,6,9-hetero-trisubstituted purine inhibitor exhibits potent biological effects against multiple myeloma cells","volume":"21","author":"Shahani","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113249","article-title":"Structural optimization towards promising \u03b2-methyl-4-acrylamido quinoline derivatives as PI3K\/mTOR dual inhibitors for anti-cancer therapy: the in vitro and in vivo biological evaluation","volume":"214","author":"He","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115102_bib114","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S1474-4422(18)30252-7","article-title":"Expanding role of GABAA receptors in generalised epilepsies","volume":"17","author":"Mefford","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2023.115102_bib115","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41586-018-0832-5","article-title":"GABAA receptor signalling mechanisms revealed by structural pharmacology","volume":"565","author":"Masiulis","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115102_bib116","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13046-019-1145-8","article-title":"NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells","volume":"38","author":"Keller","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115102_bib117","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.semcancer.2017.04.010","article-title":"The NDR\/LATS protein kinases in immunology and cancer biology","volume":"48","author":"Sharif","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib118","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2020.38.15_suppl.e13058","article-title":"Prescribing preferences for hormone sensitive (HR+) metastatic breast cancer (mBC) in the CDK 4\/6 inhibitor (CDK 4\/6i) era","volume":"38","author":"Feinberg","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2023.115102_bib119","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.tcb.2021.01.010","article-title":"New insights into CDK regulators: novel opportunities for cancer therapy","volume":"31","author":"Bury","year":"2021","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2023.115102_bib120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41392-022-00934-y","article-title":"Notch signaling pathway: architecture, disease, and therapeutics","volume":"7","author":"Zhou","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2023.115102_bib121","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1146\/annurev-biochem-040320-103615","article-title":"The wnt pathway: from signaling mechanisms to synthetic modulators","volume":"91","author":"Rim","year":"2022","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2023.115102_bib122","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","article-title":"Wnt\/beta-catenin pathway: modulating anticancer immune response","volume":"10","author":"Pai","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejmech.2023.115102_bib123","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.apsb.2019.10.003","article-title":"Targeting autophagy-related protein kinases for potential therapeutic purpose","volume":"10","author":"Xiang","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2023.115102_bib124","doi-asserted-by":"crossref","DOI":"10.1038\/nrd.2017.75","article-title":"Targeting host kinases","volume":"16","author":"Sarah","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115102_bib125","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: a pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.ejmech.2023.115102_bib126","article-title":"Neuropathic pain","volume":"3","author":"Colloca","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.ejmech.2023.115102_bib127","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-pharmtox-010818-021524","article-title":"Neuropathic pain: mechanism-based therapeutics","volume":"60","author":"Bannister","year":"2020","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejmech.2023.115102_bib128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1126\/science.aau5174","article-title":"Discovery of widespread type I and type V CRISPR-Cas inhibitors","volume":"362","author":"Marino","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115102_bib129","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1172\/JCI127907","article-title":"Targeting AML-associated FLT3 mutations with a type I kinase inhibitor","volume":"130","author":"Jones","year":"2020","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2023.115102_bib130","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s001250050787","article-title":"Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor","volume":"40","author":"Morishita","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejmech.2023.115102_bib131","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.tips.2022.04.006","article-title":"Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules","volume":"43","author":"Goebel","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejmech.2023.115102_bib132","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1136\/annrheumdis-2018-213672","article-title":"Checkpoint inhibitor-induced polymyalgia rheumatica controlled by cobimetinib, a MEK 1\/2 inhibitor","volume":"78","author":"Chan","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.ejmech.2023.115102_bib133","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41392-021-00826-7","article-title":"An overview of kinase downregulators and recent advances in discovery approaches","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejmech.2023.115102_bib134","doi-asserted-by":"crossref","first-page":"13764","DOI":"10.1002\/anie.201914525","article-title":"New promise and opportunities for allosteric kinase inhibitors","volume":"59","author":"Lu","year":"2020","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2023.115102_bib135","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1039\/C9CS00720B","article-title":"Advances in covalent kinase inhibitors","volume":"49","author":"Abdeldayem","year":"2020","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2023.115102_bib136","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/0140-6736(91)92382-C","article-title":"Chirality in antirheumatic drugs","volume":"338","author":"Kean","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115102_bib137","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nchem.2479","article-title":"Counting on natural products for drug design","volume":"8","author":"Rodrigues","year":"2016","journal-title":"Nat. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:47:33Z","timestamp":1759330053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342300017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":137,"alternative-id":["S022352342300017X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115102","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and therapeutic potential of adaptor-associated kinase 1 inhibitors in human multifaceted diseases","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115102","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115102"}}